💊Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-monitoring Device
Tokyo, Japan, November 16, 2017 — Teijin Pharma Limited Opening a new window, the core company of the Teijin Group’s healthcare business, and SRETT, a French IoT provider, announced today they have agreed to an exclusive distribution arrangement in Japan for TeleOx, a device developed by SRETT which remotely monitors patient’s respiratory functionsin oxygen therapy.